MA Labs

MAA Laboratories is a technology-driven specialty pharmaceutical company based in Research Triangle Park, North Carolina, focused on developing clinically differentiated therapies through its proprietary NanoCont™ platform. The company specializes in nanoparticle-based drug development and continuous manufacturing to overcome limitations of traditional drug products, such as poor bioavailability, food-effect variability, and dose-related toxicity. MAA Laboratories is advancing a diverse pipeline of reformulated drug products targeting high-need areas including oncology, neurology, and inflammatory diseases. By utilizing the 505(b)(2) regulatory pathway, the company aims to bring improved versions of existing molecules to market with reduced risk and accelerated development timelines.